🇺🇸 FDA
Patent

US 9283300

Use of midkine protein and the protein-containing medical device

granted A61KA61K38/18A61P

Quick answer

US patent 9283300 (Use of midkine protein and the protein-containing medical device) held by GENERAL REGENERATIVES, LTD. expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENERAL REGENERATIVES, LTD.
Grant date
Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/18, A61P, A61P19/00, A61P19/02